Tango Therapeutics, Inc.·4

Jun 7, 5:21 PM ET

Peters Malte 4

4 · Tango Therapeutics, Inc. · Filed Jun 7, 2024

Insider Transaction Report

Form 4
Period: 2024-06-05
Peters Malte
DirectorPresident & CEO
Transactions
  • Award

    Common Stock

    2024-06-05+6,25011,250 total
  • Award

    Stock Option (Right to Buy)

    2024-06-05+37,50037,500 total
    Exercise: $7.41Exp: 2034-06-05Common Stock (37,500 underlying)
Footnotes (2)
  • [F1]These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest in its entirety on the earlier of: (i) June 5, 2025 and (iii) the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.
  • [F2]This option shall vest and become exercisable in 12 substantially equal monthly installments over a period of one year beginning on July 5, 2024, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4